InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Caffo Nathan, Directeur Commercial. Director active across 1 companies, notably Candel Therapeutics, Inc.. In total, 2 filings have been recorded. Total volume traded: €81k. The latest transaction was disclosed on 29 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€40,3606,000 shares@ €6.7266100.0% of flow
Common Stock
SEC:0000899243-21-031086·
Ideal exit: 25 Apr 2022 (T+270)
€40,3606,000 shares@ €6.72660.013% mcap50.0% of flow
Common Stock
SEC:0000899243-21-031086:0·
Ideal exit: 25 Apr 2022 (T+270)
2 of 2 declarations
About Caffo Nathan
Caffo Nathan is the Chief Business Officer at Candel Therapeutics, Inc. In this role, he is responsible for business strategy and partnership development. His expertise in the biopharmaceutical sector enables him to guide the company towards sustainable growth. Nathan works closely with teams to align business initiatives with strategic objectives.
